# E-DRUG: Drug Prices in Pakistan

**URL:** <https://talk.edrugplus.org/t/e-drug-drug-prices-in-pakistan/3878>\
**Category:** e-drug\
**Created:** [November 19, 1998, 8:46pm UTC](https://talk.edrugplus.org/t/e-drug-drug-prices-in-pakistan/3878 "1998-11-19T20:46:54Z")\
**Posts on this page:** 1\
**Page:** 1

<div class="post-metadata">

**Author:** ![joel.lexchin](https://avatars.discourse-cdn.com/v4/letter/j/e9c0ed/32.png) [@joel.lexchin](https://talk.edrugplus.org/u/joel.lexchin)\
**Post date:** [November 19, 1998, 8:46pm UTC](https://talk.edrugplus.org/t/e-drug-drug-prices-in-pakistan/3878/1 "1998-11-19T20:46:54Z")

</div>

E-DRUG: Drug Prices in Pakistan (cont)  
--------------------------------------

I would add to Foppe van Mil's list of questions some of my own:

1) What percent of the drugs that Lilly sells in Pakistan is on the  
essential drug list?

2) How do the prices for drugs on the essential drug list compare to those  
that are not on the list?

3) Does Lilly have its own internal marketing code or does it rely on the  
ineffective code from the IFPMA?

4) How do the listed indications and safety warnings for the drugs that  
Lilly markets in Pakistan compare to the indications and safety warnings in  
countries like the U.S. or Canada?

Joel Lexchin

Joel Lexchin MD  
121 Walmer Rd.  
Toronto, Ontario  
CANADA M5R 2X8  
Phone: (416)-964-7186  
Fax: (416)-923-9515  
e mail: joel.lexchin@utoronto.ca

--  
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.  
Mail administrative requests to `majordomo@usa.healthnet.org'.  
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.
